These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

536 related articles for article (PubMed ID: 6085363)

  • 1. Antihypertensive effects on blood pressure at rest and during exercise of calcium antagonists, beta-receptor blockers, and their combination in hypertensive patients.
    Franz IW; Wiewel D
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1037-42. PubMed ID: 6085363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Antihypertensive effect of nitrendipine, nifedipine and acebutolol and their combination on resting and exercise blood pressure in hypertensive patients].
    Franz IW; Wiewel D
    Z Kardiol; 1985 Feb; 74(2):111-6. PubMed ID: 3158125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of beta-receptor antagonists and diuretics and their combination on blood pressure and pressure-rate product during ergometric work in hypertensive patients (author's transl)].
    Franz IW
    Z Kardiol; 1982 Jan; 71(2):129-37. PubMed ID: 7072313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of the alpha 1-receptor blocker prazosin and the beta 1-receptor blocker acebutolol and their combination on blood pressure and pressure rate product. Ergometric studies of hypertensive patients].
    Franz IW
    Z Kardiol; 1984 Jan; 73(1):21-8. PubMed ID: 6367245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bisoprolol and acebutolol on resting blood pressure and on exercise blood pressure profile in hypertensive patients: a comparative, single-blind study.
    Bouvier JM; Rabot D; Herrero G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S179-83. PubMed ID: 11527124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive therapy with the long-acting calcium antagonist nitrendipine.
    Müller FB; Bolli P; Erne P; Block LH; Kiowski W; Bühler FR
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1073-6. PubMed ID: 6085370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and long-term effects of nitrendipine on resting and exercise hemodynamics in essential hypertension.
    Nannan ME; Melin JA; Vanbutsele RJ; Lavenne F; Detry JM
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1043-8. PubMed ID: 6085364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The calcium channel blocker nitrendipine in single- and multiple-agent antihypertensive regimens: preliminary report of a multicenter study.
    Weber MA; Drayer JI
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1077-84. PubMed ID: 6085371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Addition of urapidil or metoprolol to the treatment of hypertensive non-responders to nifedipine monotherapy: efficacy and metabolic effects. Italian Urapidil Study Group.
    Zanchetti A
    Blood Press Suppl; 1995; 3():38-46. PubMed ID: 8535541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parallel reduction of calcium-influx-dependent vasoconstriction and platelet-free calcium concentration with calcium entry and beta-adrenoceptor blockade.
    Bolli P; Erne P; Hulthén UL; Ritz R; Kiowski W; Ji BH; Bühler FR
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S996-1001. PubMed ID: 6085391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitrendipine in hypertension that is difficult to control.
    Höffler D; Stoepel K
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1060-2. PubMed ID: 6085367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of calcium antagonist, angiotensin-converting enzyme inhibitors and beta-blocker on hemodynamic and sympathetic nerve responses to exercise in essential hypertension].
    Fujiwara S; Arita M; Ueno Y; Shiotani M; Nakatsu C; Nakamura Y; Hano T; Nishio I; Masuyama Y
    J Cardiol; 1991; 21(1):115-24. PubMed ID: 1687786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Nitrendipine, a new calcium antagonist, in the therapy of arterial hypertension].
    Cosmi F; Mollaioli M; Aimi M; Conti G; Corbacelli C; Bianco C; Ricca M
    Minerva Med; 1985 Nov; 76(42):1983-90. PubMed ID: 2933597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of nitrendipine as baseline antihypertensive therapy.
    Rüddel H; Schmieder R; Langewitz W; Neus J; Wagner O; von Eiff AW
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1049-52. PubMed ID: 6085365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium antagonists, firstline partners for betablockers in hypertension.
    Bühler FR
    Z Kardiol; 1984; 73 Suppl 2():95-9. PubMed ID: 6152093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nifedipine and acebutolol in combination for the treatment of moderate to severe essential hypertension.
    Singer DR; Markandu ND; Shore AC; MacGregor GA
    J Hum Hypertens; 1987 Jun; 1(1):31-7. PubMed ID: 3334056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiac ischemia on exercise. Effect of nifedipine and acebutolol singly and in combination (author's transl)].
    Strasser R; Klepzig H
    MMW Munch Med Wochenschr; 1981 Aug; 123(35):1303-6. PubMed ID: 6793850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of moderate hypertension with the calcium antagonist nitrendipine in combination with beta receptor blocker or diuretic].
    Overlack A; Müller HM; Kolloch R; Stumpe KO
    Med Klin (Munich); 1990 Aug; 85(8):467-71. PubMed ID: 2233598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medium-term effects of betaxolol monotherapy and combination therapy with nitrendipine on lipoprotein and apolipoprotein metabolism in patients with mild to moderate essential hypertension.
    Saku K; Zhang B; Okamoto T; Takeda Y; Liu K; Jimi S; Arakawa K
    J Hum Hypertens; 1996 Apr; 10(4):263-8. PubMed ID: 8736459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with long-term nitrendipine treatment in essential hypertension.
    Tourkantonis A; Lasaridis A; Settas L
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S1090-5. PubMed ID: 6085373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.